arrow
J

Jennifer Lyons

biogen, cambridge, ma, usa
H指数:27
被引数:2,731

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety and efficacy of opicinumab in participants with relapsing multiple sclerosis (AFFINITY Part 1): A randomized, controlled, phase 2 trial

奥匹克单抗在复发型多发性硬化患者中的安全性与有效性(AFFINITY试验第1部分):一项随机、对照的2期临床试验

2025-12-260
PRE
Efficacy and Safety Outcomes with Diroximel Fumarate After Switching from Prior Therapies or Continuing on DRF: Results from the Phase 3 EVOLVE-MS-1 Study
2022-02-2427
OAAI